We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Cardinal Health
CAH
$53.4B
| $31.6M | 0.09% |
473,600
+325,600
| +220% | +$20.6M |
|
|
227
Occidental Petroleum
OXY
$57B
| $31.5M | 0.09% |
512,600
-5,016,800
| -91% | -$321M |
|
228
New Oriental
EDU
$7.84B
| $31.4M | 0.09% |
1,308,869
-671,600
| -34% | -$16.7M |
|
229
Blackstone
BX
$104B
| $31.2M | 0.09% |
373,000
+39,300
| +12% | +$3.81M |
|
230
InMode
INMD
$872M
| $31M | 0.09% |
1,066,500
-507,300
| -32% | -$15.7M |
|
231
StoneCo
STNE
$2.62B
| $30.9M | 0.09% |
3,246,700
+5,900
| +0.2% | +$56.5K |
|
232
Coca-Cola Europacific Partners
CCEP
$46.5B
| $30.9M | 0.09% |
725,000
+625,400
| +628% | +$31.4M |
|
233
Ferrari
RACE
$63.3B
| $30.6M | 0.09% |
165,200
-17,500
| -10% | -$3.49M |
|
234
Manhattan Associates
MANH
$8.97B
| $30.4M | 0.09% |
228,200
-9,600
| -4% | -$1.3M |
|
235
Devon Energy
DVN
$51.9B
| $30.3M | 0.09% |
504,672
+90,100
| +22% | +$5.6M |
|
236
Macy's
M
$6.15B
| $30.3M | 0.09% |
1,931,282
-2,298,900
| -54% | -$40.7M |
|
237
Jack Henry & Associates
JKHY
$10.7B
| $30.1M | 0.09% |
165,400
-101,100
| -38% | -$19.8M |
|
238
Frontline
FRO
$8.75B
| $30.1M | 0.09% |
2,750,780
+1,322,580
| +93% | +$14.5M |
|
239
State Street
STT
$50.9B
| $29.5M | 0.09% |
484,900
-65,000
| -12% | -$4.44M |
|
240
Ionis Pharmaceuticals
IONS
$9.35B
| $29.1M | 0.08% |
657,511
-48,300
| -7% | -$2.04M |
|
|
VRN
241
DELISTED
Veren
VRN
| $28.9M | 0.08% |
4,688,435
-328,900
| -7% | -$2.35M |
|
242
United Parks & Resorts
PRKS
$2.11B
| $28.8M | 0.08% |
632,400
-110,700
| -15% | -$5.51M |
|
243
Royalty Pharma
RPRX
$26.1B
| $28.5M | 0.08% |
708,800
-43,200
| -6% | -$1.85M |
|
244
Eli Lilly
LLY
$1.07T
| $28.5M | 0.08% |
88,000
-324,100
| -79% | -$103M |
|
245
SBA Communications
SBAC
$18.4B
| $28.4M | 0.08% |
99,700
+20,600
| +26% | +$6.69M |
|
246
Transocean
RIG
$5.92B
| $28.4M | 0.08% |
11,479,486
+1,510,078
| +15% | +$4.83M |
|
|
JWN
247
DELISTED
Nordstrom
JWN
| $28.2M | 0.08% |
1,683,801
-1,526,900
| -48% | -$31.9M |
|
248
Teleflex
TFX
$5.85B
| $27.8M | 0.08% |
138,100
+28,300
| +26% | +$6.77M |
|
249
CoStar Group
CSGP
$11.3B
| $27.7M | 0.08% |
398,300
-814,600
| -67% | -$56.6M |
|
|
BRSL
250
Brightstar Lottery PLC
BRSL
$1.91B
| $27.6M | 0.08% |
1,748,700
-118,900
| -6% | -$2.23M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.